John F Crowley Entrada Therapeutics, Inc. (TRDA) insider trading activity

TRDA Quotes by TradingView

John F Crowley is Director of Entrada Therapeutics, Inc.. Currently has a direct ownership of 5,000 shares of TRDA, which is worth approximately $79,950. The most recent transaction as insider was on Jan 12, 2022, when has been sold 5,000 shares (Common Stock) at a price of $9.71 per share, resulting in proceeds of $48,550. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $79,950

John F Crowley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2022
BUY
Open market or private purchase
$48,550 $9.71 p/Share
5,000 Added 50.0%
5,000 Common Stock

Also insider at

FOLD
AMICUS THERAPEUTICS, INC. Healthcare
Executive Chairman
NTLA
Intellia Therapeutics, Inc. Healthcare
Director
JFC

John F Crowley

Director
Boston, MA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRDA